Acacia Pharma has a late-stage pipeline of product candidates in development for post-operative and cancer supportive care; large and growing markets with significant unmet medical need.
Post-operative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Acacia Pharma Announces Positive Results From Phase 2 Study With APD403 In CINV
Phase 3 Combination Prophylaxis Study Initiated With APD421 In PONV
Scott Byrd and Christine Soden Appointed to Board of Directors
View all news